- Messages
- 6,107
- Type of diabetes
- Type 2
- Treatment type
- Diet only
As Angela Magny, Public Affairs Manager, Roche Diabetes
Care pointed out that a key element of the variation in
strip restriction is the adoption of local formularies
by CCGs for blood glucose monitoring. Although NICE
published guidelines on the development of local
formulary guidelines in December 2012, they failed to
adequately cover medical technology, including the
products used to self-test blood glucose.
Care pointed out that a key element of the variation in
strip restriction is the adoption of local formularies
by CCGs for blood glucose monitoring. Although NICE
published guidelines on the development of local
formulary guidelines in December 2012, they failed to
adequately cover medical technology, including the
products used to self-test blood glucose.